Skip to main content
. 2023 Jul 21;13:11795. doi: 10.1038/s41598-023-38596-7

Figure 7.

Figure 7

NVS-ZP7-4 inhibited HCC in vivo. (A,B) Subcutaneous tumor formation in Huh7 xenograft tumors in mice intraperitoneal injected with the NVS-ZP7-4 or DMSO for 2 weeks. (C) Quantification of the tumor weight was shown. (D) Representative HE staining, p-AKT and the proliferation marker PCNA, the apoptosis marker cleaved caspase-3 of xenografts treated with the NVS-ZP7-4 and DMSO. Scale bars: 100 μm. *p < 0.05 versus Control.